Outcomes of bacterial meningitis in children

C Briand1, C Levy2, F Baumie1

  • 1Service de pédiatrie, hôpital Jean-Verdier, université Paris 13, AP-HP, 93140 Bondy, France.

Insights

Long-term follow-up for pediatric bacterial meningitis is variable, with 32% of children experiencing sequelae. Standardized national surveillance is recommended to improve outcomes and track long-term effects.

Area of Science:

  • Pediatric Infectious Diseases
  • Neurology
  • Public Health

Background:

  • Bacterial meningitis poses immediate risks to children, but long-term outcomes are not well-documented.
  • Understanding the sequelae of pediatric bacterial meningitis is crucial for effective patient management.

Purpose of the Study:

  • To evaluate the duration and quality of long-term follow-up for children with bacterial meningitis.
  • To estimate the incidence of sequelae in children post-bacterial meningitis.
  • To compare follow-up data with existing literature.

Main Methods:

  • Retrospective study of 34 children (3 months-15 years) hospitalized for bacterial meningitis between 2001 and 2013.
  • Analysis of follow-up duration, sequelae incidence, and specific outcomes like seizures and hearing loss.

Main Results:

  • 32% of patients developed sequelae, and 15% experienced seizures.
  • Hearing loss was observed in one patient, with 23.5% lacking hearing tests.
  • Neuropsychological assessments in seven patients revealed no severe sequelae; follow-up duration increased over the study period.

Conclusions:

  • Significant variability exists in long-term follow-up practices for pediatric bacterial meningitis.
  • A standardized follow-up protocol is necessary.
  • Implementation via a national surveillance network is proposed to improve monitoring and outcomes.
Abstract

Related Concept Videos

Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
30
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
47
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
540
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
618
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.0K
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
3.0K